Few nutrition policies have achieved the iconic status of folic acid fortification. Public health authorities introduced the measure to reduce neural tube defects (NTDs), and early data appeared convincing. Incidence rates declined, and fortification quickly became framed as an unquestionable success.

Science, however, rarely stands still.

Newer research invites a more nuanced but also uncomfortable conversation. The question no longer centers on whether folate matters. Folate clearly plays a critical role in early fetal development. It is also involved in reducing autism risk if supplements are taken early enough before conception. The real debate focuses on whether mandatory folic acid fortification remains the optimal and safest strategy for entire populations.

---

Were the Original Studies Truly Definitive?

Fortification policies relied heavily on observational population data. Researchers observed declining NTD rates following implementation and inferred causality. In reality, correlation does not automatically confirm causation.

Recent analyses highlight potential confounding variables, including:

• Improvements in prenatal care
• Increased supplement use
• Better diagnostic methods
• Changes in pregnancy termination practices

Several researchers now argue that the magnitude of fortification’s effect may have been overstated. Some studies lacked the methodological rigor required to isolate folic acid as the sole driver of declining NTD rates (De-Regil et al., Cochrane Review updates).

This does not negate benefits but it does challenge certainty. Public policy demands a higher threshold than plausibility.

The Issue of Unmetabolized Folic Acid (UMFA)

Synthetic folic acid differs from naturally occurring folates. The body must convert it into metabolically active forms. When intake exceeds enzymatic capacity, folic acid can circulate unmetabolized in the bloodstream.

Researchers continue to investigate the biological implications of unmetabolized folic acid (UMFA). Emerging concerns include possible associations with:

• Altered immune responses
• Masking of vitamin B12 deficiency
• Changes in epigenetic regulation
• Potential effects on cancer biology

The evidence remains incomplete, but uncertainty alone warrants attention. A national policy should prioritize safety margins for all individuals, including those with higher exposure from fortified foods combined with supplements (Bailey & Ayling, AJCN).

Genetic Variability: A Central Blind Spot

Human metabolism varies significantly.

Variants in genes such as MTHFR influence folate processing efficiency. While many authorities emphasize that individuals with MTHFR variants can still metabolize folic acid, research increasingly suggests that metabolic responses differ meaningfully across genotypes. There is also the false sense of security of not having this mutation, because every human is not really good at converting folic acid because of the DHFR enzyme being so much more effective than we first thought it to be.

Mandatory fortification assumes uniform metabolic handling. Biology does not support that assumption.

Precision nutrition principles now dominate many areas of nutritional science. Yet fortification policies continue to rely on a population-wide model developed decades ago. This deserves discussion, and maybe we should do more studies where sample population is divided into the different variants.

Supplementation: A Changing Landscape

Fortification originally addressed a practical challenge: many pregnancies were unplanned, and supplement adherence remained inconsistent.

Today, supplement use has dramatically increased.

Prenatal supplementation now represents standard medical advice. Individuals can also choose metabolically active forms such as 5-methyltetrahydrofolate (5-MTHF), which bypass key conversion steps.

This shifts the policy equation. If supplementation already covers most at-risk individuals, does mandatory fortification still offer the same risk-benefit advantage? The answer may vary by population, but the question remains scientifically legitimate.

Safety Must Be Universal, Not Statistical

Public health policies often accept small risks for large benefits. However, nutrition policies differ from vaccines or medications (for which people ultimately always have a choice to take them or not) in one key aspect: Everyone consumes food. Every day. For life.

A policy that increases exposure to a synthetic compound should demonstrate long-term safety across diverse genetic, metabolic, and age-related profiles. In that sense, scrutiny is justified.

One can acknowledge that:

• Folate plays an essential biological role
• Fortification likely contributed to improved folate status
• Knowledge gaps persist regarding chronic high exposure
• Genetic variability complicates uniform recommendations

Science evolves. Policy should evolve with it.

In conclusion: Rethink folic acid fortification!

Questioning folic acid fortification does not equate to questioning folate’s importance. It reflects a deeper commitment to scientific rigor, individualized biology, and long-term safety.

Public health measures must withstand continuous evaluation. That is not controversy, that is good science and a healthy debate compatible with a democratic world. If more studies are needed, more studies are needed!

Want to dive deeper on folic acid fortification? Read this article

References

Whitehead VM, Kamen BA, Beaulieu D. Levels of dihydrofolate reductase in livers of birds, animals, primates, and man. Cancer Drug Delivery. 1987;4(3):185-189. doi:10.1089/cdd.1987.4.185.

Bailey, S. W., & Ayling, J. E. Unmetabolized Folic Acid: Implications for Health
American Journal of Clinical Nutrition.

De-Regil, L. M., Peña-Rosas, J. P., Fernández-Gaxiola, A. C., & Rayco-Solon, P.
Effects and Safety of Folic Acid Fortification Cochrane Database of Systematic Reviews.

National Institutes of Health (NIH) – Office of Dietary Supplements. Folate Fact Sheet for Health Professionals https://ods.od.nih.gov/factsheets/Folate-HealthProfessional/

World Health Organization (WHO) Guideline: Fortification of Food with Micronutrients

Abate, B. B. et al. (2025) Umbrella Review on Maternal Folic Acid and Neurodevelopmental Outcomes
PLOS ONE.